Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (99)

2024

  1. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    Sleep Medicine, Vol. 116, pp. 19-26

  2. Genetic risk score based on obesity-related genes and progression in weight loss after bariatric surgery: a 60-month follow-up study

    Surgery for Obesity and Related Diseases

  3. Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  4. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019

    Primary Care Diabetes

  5. Use of polygenic risk scores to assess weight loss after bariatric surgery: a 5-year follow-up study

    Journal of Gastrointestinal Surgery

2023

  1. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 48

  2. Assessment of dyspneic sensation in patients with type 2 diabetes

    Frontiers in Endocrinology, Vol. 14

  3. Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study

    Frontiers in Psychology, Vol. 14

  4. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies

    Nutrients, Vol. 15, Núm. 5

  5. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

    Atherosclerosis, Vol. 375, pp. 75-83

  6. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

    Nutrients, Vol. 15, Núm. 1

  7. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

  8. Mutual modulation of gut microbiota and the immune system in type 1 diabetes models

    Nature Communications, Vol. 14, Núm. 1

  9. NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development

    Frontiers in Endocrinology, Vol. 14

  10. Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis

    STAR Protocols, Vol. 4, Núm. 4

2022

  1. Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy

    Diabetes Therapy, Vol. 13, Núm. 7, pp. 1281-1298

  2. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications

    Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888

  3. Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study

    Scientific Reports, Vol. 12, Núm. 1

  4. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study

    Frontiers in Cardiovascular Medicine, Vol. 9

  5. Effectiveness of medical nutrition therapy in adolescents with type 1 diabetes: a systematic review

    Nutrition and Diabetes, Vol. 12, Núm. 1